# nQ Medical, Inc. — Form D

nQ Medical, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-19. The offering totals $1.6M, of which $1.5M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2018-11-19
- Form: D
- Accession: 0001144204-18-060594
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.5M
- Remaining: $100K
- Minimum investment: $10K
- Investors: 27
- Date of first sale: 2018-11-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326053

## Issuer

- Name: nQ Medical, Inc.
- CIK: 0001758823
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1 BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-429-6060

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Richie Bavasso | Director | Cambridge, MA |
| Gregory Murdock | Director | New York, NY |
| Mark Pascarella | Director | Cambridge, MA |
| Richie Bavasso | Executive Officer | Cambridge, MA |

## More

- [CIK 1758823 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1758823&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001144204-18-060594.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.